Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorİnan Ergün, Aslı
dc.contributor.authorTopal, Meryem
dc.date.accessioned2023-11-16T07:44:30Z
dc.date.available2023-11-16T07:44:30Z
dc.date.issued2023en_US
dc.identifier.citationİnan Ergün, Aslı a Send mail to İnan Ergün A.;Topal, Meryem p b Send mail to Topal M. Save all to author list a Gumushane University, Graduate Education Institute, Gumushane, 29100, Turkey b Gumushane University, Vocational School of Health Services, Gumushane, 29100, Turkeyen_US
dc.identifier.urihttps://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/slct.202302751
dc.identifier.urihttps://hdl.handle.net/20.500.12440/6085
dc.description.abstractPuerarin, which was used as a natural isoflavone in this study, was obtained from the Kudzu plant. The inhibitory effect of puerarin on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes was investigated. The IC50 values of AChE (177.73 nM) and BChE (315.07 nM) were determined. The binding mechanism of puerarin, which has a high inhibitory effect on the active site of the enzyme, was demonstrated by the molecular docking method. The antioxidant activity was evaluated for the same molecule. For this purpose, Fe3+-Fe2+ reducing capacity, ABTS radical scavenging activity, CUPRAC method, DPPH⋅ scavenging activity and DMPD radical scavenging method were used. The percentage (%) inhibition amount of puerarin molecule was calculated as 99.33 % for ABTS radical scavenging activity, which is the more preferred method for natural products. The absorbtion value of iron reduction of Puerarin was 0.122±0.010, and the value of copper reduction was 0.633±0.026. Our research efforts include uncovering the potent antioxidant potential of puerarin and, simultaneously, a comparative study of tacrine, primarily emphasizing its inhibitory effects against AChE and BChE enzymes. The puerarin is expected to be a guide for drug discovery against many problems, especially oxidative cell damage in Alzheimer's disease, mitochondrial dysfunction (MD), cancer, and cardiovascular diseases. © 2023 Wiley-VCH GmbH.en_US
dc.language.isoengen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.relation.ispartofChemistrySelecten_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.subjectAntioxidant activityen_US
dc.subjectEnzymeen_US
dc.subjectMolecular dockingen_US
dc.subjectPhenolic compounden_US
dc.subjectPuerarinen_US
dc.titleDetermination of the Antioxidant Capacity of Puerarin and Its Effect on Cholinesterases by in vitro and in silico Methodsen_US
dc.typearticleen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.departmentMeslek Yüksekokulları, Gümüşhane Sağlık Hizmetleri Meslek Yüksekokulu, Tıbbi Hizmetler ve Teknikler Bölümüen_US
dc.authorid0000-0002-2107-8603en_US
dc.contributor.institutionauthorTopal, Meryem
dc.identifier.doi10.1002/slct.202302751en_US
dc.authorwosidABG-5541-2021en_US
dc.authorscopusid55929192400en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster